Evidence map›Paper›PMID 36602863›Full record

ArticleJCI insight2023

Targeting HuR-Vav3 mRNA interaction prevents Pseudomonas aeruginosa adhesion to the cystic fibrosis airway epithelium.

Mehdi Badaoui, Cyril Sobolewski, Alexandre Luscher, Marc Bacchetta, Thilo Köhler, Christian van Delden, Michelangelo Foti, Marc Chanson

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. HuR-Targeted Small Molecules ReduceInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Disrupting the TGF-β-Wnt Balance to Control the Polarity of the Cystic Fibrosis Airway Epithelium.American journal of respiratory cell and molecular biology · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mehdi BadaouiDepartment of Cell Physiology & Metabolism and.
Cyril SobolewskiDepartment of Cell Physiology & Metabolism and.
Alexandre LuscherDepartment of Microbiology & Molecular Medicine, Faculty of Medicine, University of Geneva, Switzerland.
Marc BacchettaDepartment of Cell Physiology & Metabolism and.
Thilo KöhlerDepartment of Microbiology & Molecular Medicine, Faculty of Medicine, University of Geneva, Switzerland.
Christian van DeldenDepartment of Microbiology & Molecular Medicine, Faculty of Medicine, University of Geneva, Switzerland.
Michelangelo FotiDepartment of Cell Physiology & Metabolism and.
Marc ChansonDepartment of Cell Physiology & Metabolism and.
University of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cystic fibrosis (CF) is characterized by chronic bacterial infections leading to progressive bronchiectasis and respiratory failure. Pseudomonas aeruginosa (Pa) is the predominant opportunistic pathogen infecting the CF airways. The guanine nucleotide exchange factor Vav3 plays a critical role in Pa adhesion to the CF airways by inducing luminal fibronectin deposition that favors bacteria trapping. Here we report that Vav3 overexpression in CF is caused by upregulation of the mRNA-stabilizing protein HuR. We found that HuR accumulates in the cytoplasm of CF airway epithelial cells and that it binds to and stabilizes Vav3 mRNA. Interestingly, disruption of the HuR-Vav3 mRNA interaction improved the CF epithelial integrity, inhibited the formation of the fibronectin-made bacterial docking platforms, and prevented Pa adhesion to the CF airway epithelium. These findings indicate that targeting HuR represents a promising antiadhesive approach in CF that can prevent initial stages of Pa infection in a context of emergence of multidrug-resistant pathogens.

Indexed as

Cystic FibrosisProto-Oncogene Proteins c-vavPseudomonas aeruginosaRespiratory SystemELAV-Like Protein 1EpitheliumFibronectinsHumansELAVL1 protein, humanELAV-Like Protein 1FibronectinsProto-Oncogene Proteins c-vavVAV3 protein, humanCell BiologyExtracellular matrixFibronectinInfectious diseaseTranscription

Identifiers

PMID36602863
PMCPMC9977432
OpenAlexW4313543491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.